<DOC>
	<DOCNO>NCT00758459</DOCNO>
	<brief_summary>The primary aim study investigate tolerability safety AZD 1236 compare placebo ( `` inactive substance '' ) COPD patient assessment Adverse Events , vital sign laboratory safety assessment .</brief_summary>
	<brief_title>Safety/Tolerability Study With AZD1236 Chronic Obstructive Pulmonary Disease ( COPD ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Diagnosis COPD 1 month Men postmenopausal woman Spirometry value indicate reduce lung function Smoking history equivalent use 20 cigarette day 10 year Any current respiratory tract disorder COPD Requirement regular oxygen therapy Use oral parenteral glucocorticosteroids within 30 day prior study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>COPD</keyword>
</DOC>